Zobrazeno 1 - 10
of 37
pro vyhledávání: '"V R, Abdrakhmanov"'
Autor:
N. I. Gaponova, V. R. Abdrakhmanov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 3, Pp 340-348 (2024)
Activation of the sympathetic nervous system plays an important role in arterial hypertension (AH) development. Antihypertensive drugs of central action contribute to the elimination of sympathetic activation. The selective imidazoline receptor agoni
Externí odkaz:
https://doaj.org/article/188b242ad29f4153b25e1cabf3d3ebce
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 6, Pp 951-957 (2019)
Aim. Investigation of comparative dissolution kinetics of generic medicinal products containing moxonidine versus reference drug. Material and methods. Objects of the research were film-coated tablets containing moxonidine (INN) in a dose 0.4 mg: a r
Externí odkaz:
https://doaj.org/article/e6480de80b21477b8c38c63b8ba94848
Autor:
N I Gaponova, V R Abdrakhmanov
Publikováno v:
Системные гипертензии, Vol 13, Iss 3, Pp 64-68 (2016)
The review shows the results of the use of prolonged release verapamil (Isoptin® SR) in clinical practice. Numerous randomized clinical studies confirm the high efficiency and safety of Isoptin® SR in patients with arterial hypertension, as well as
Externí odkaz:
https://doaj.org/article/3cd01e8d795c49058884c2db66f3daf4
Autor:
K. A. Mayanskaya, R. S. Abdrakhmanova, D. A. Valimukhametova, L. S. Nizamutdinova, V. R. Abdrakhmanov
Publikováno v:
Kazan medical journal. 50:34-37
This paper presents the results of a comprehensive study of violations of gas exchange in the lungs (in terms of lung volumes, uniformity of distribution of inhaled gas, diffusion of gases in the alveolo-capillary system of the lungs), deviations of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e907bea16490db1ed4fced3345322bf2
https://doi.org/10.17816/kazmj101014
https://doi.org/10.17816/kazmj101014
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 5, Pp 703-707 (2015)
Results of experimental and clinical studies devoted to urapidil combining central antihypertensive effect with peripheral vasodilatation are discussed. Scope of urapidil application is described; its good tolerability and safety are highlighted. Ura
Externí odkaz:
https://doaj.org/article/47ae400ceb9b4cbca59ad771de6dfac1
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 5, Pp 559-564 (2015)
Results of clinical trials devoted to urapidil, antihypertensive drug having central and peripheral mode of actions are reviewed. Target groups of patients for urapidil use are specified. Dosage regimen and methods of urapidil use in different clinic
Externí odkaz:
https://doaj.org/article/8fd6027724254074ae8d61b7cd2081c8
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 13, Iss 1, Pp 57-63 (2014)
The paper reviews the clinical practice potential of a combined action antihypertensive medication urapidil for the treatment of patients with acute elevation of blood pressure (BP) and confirms urapidil effectiveness and good tolerability. Urapidil
Externí odkaz:
https://doaj.org/article/75735e21ab0b407ab183d832e553c39a
Publikováno v:
Системные гипертензии, Vol 10, Iss 1, Pp 40-47 (2013)
Aim. To evaluate the clinical efficacy and safety of the selective imidazoline I1-receptor agonist moxonidine versus the angiotensin-converting enzyme inhibitor captopril in patients with uncomplicated hypertensive crisis (UHC). Subjects and methods.
Externí odkaz:
https://doaj.org/article/ec90269074274395b3305634eaa27a13
Publikováno v:
Системные гипертензии, Vol 8, Iss 4, Pp 32-39 (2011)
Externí odkaz:
https://doaj.org/article/45542250ca904c19b86dd33014167c9c
Autor:
S N Tereshchenko, V R Abdrakhmanov, N I Gaponova, T M Uskach, I V Kostsina, V V Skibitskiy, Zh D Kobalava, N Kh Bagmanova, Yu I Grinshteyn, V V Shabalin, L N Pletneva, Yu M Lopatin, AOKonradi RS Karpov, V F Mordovin, E V Tsymbalyuk, E A Shutemova, A R Kiselev
Publikováno v:
Системные гипертензии, Vol 7, Iss 4, Pp 48-53 (2010)
Externí odkaz:
https://doaj.org/article/8672eb79838748c59efb4126f22950d8